Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hon-Wah Man

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The Journal of Organic Chemistry|November 1, 1996
Direct Synthesis of [alpha-[(tert-Butoxycarbonyl)amino]alkyl]- boronates from (alpha-Haloalkyl)boronatesPrabhakar K. Jadhav, Hon-Wah Man
Bioorganic & Medicinal Chemistry Letters|September 25, 2003
Alpha-fluoro-substituted thalidomide analoguesHon-Wah Man, Laura G Corral, David I Stirling, et al.
Oncology Research|December 3, 2003
Effect of 3-fluorothalidomide and 3-methylthalidomide enantiomers on tumor necrosis factor production and antitumor responses to the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA)Francisco Chung, Brian D Palmer, George W Muller, et al.
Pancreas|January 1, 2009
Antiproliferative effects of CC-8062 and CC-8075 in pancreatic cancer cellsPetros X E Mouratidis, Kay W Colston, Jake Blake Bartlett, et al.
Cancer Research|December 18, 2003
Selective cytokine inhibitory drugs with enhanced antiangiogenic activity control tumor growth through vascular inhibitionMichael S Gee, Sosina Makonnen, Khalid al-Kofahi, et al.
Cancer Research|February 5, 2003
A novel subclass of thalidomide analogue with anti-solid tumor activity in which caspase-dependent apoptosis is associated with altered expression of bcl-2 family proteinsJ Blake Marriott, Ian A Clarke, Anna Czajka, et al.
Bioorganic & Medicinal Chemistry|September 30, 2011
1,1-Diarylalkenes as anticancer agents: dual inhibitors of tubulin polymerization and phosphodiesterase 4Alexander L Ruchelman, Hon-Wah Man, Roger Chen, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2012
Isosteric analogs of lenalidomide and pomalidomide: synthesis and biological activityAlexander L Ruchelman, Hon-Wah Man, Weihong Zhang, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2003
Enhancement of cytokine production and AP-1 transcriptional activity in T cells by thalidomide-related immunomodulatory drugsPeter H Schafer, Anita K Gandhi, Michelle A Loveland, et al.
Microvascular Research|September 23, 2008
The anti-cancer drug lenalidomide inhibits angiogenesis and metastasis via multiple inhibitory effects on endothelial cell function in normoxic and hypoxic conditionsLing Lu, Faribourz Payvandi, Lei Wu, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The Journal of Organic Chemistry|November 1, 1996
Direct Synthesis of [alpha-[(tert-Butoxycarbonyl)amino]alkyl]- boronates from (alpha-Haloalkyl)boronatesPrabhakar K. Jadhav, Hon-Wah Man
Bioorganic & Medicinal Chemistry Letters|September 25, 2003
Alpha-fluoro-substituted thalidomide analoguesHon-Wah Man, Laura G Corral, David I Stirling, et al.
Oncology Research|December 3, 2003
Effect of 3-fluorothalidomide and 3-methylthalidomide enantiomers on tumor necrosis factor production and antitumor responses to the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA)Francisco Chung, Brian D Palmer, George W Muller, et al.
Pancreas|January 1, 2009
Antiproliferative effects of CC-8062 and CC-8075 in pancreatic cancer cellsPetros X E Mouratidis, Kay W Colston, Jake Blake Bartlett, et al.
Cancer Research|December 18, 2003
Selective cytokine inhibitory drugs with enhanced antiangiogenic activity control tumor growth through vascular inhibitionMichael S Gee, Sosina Makonnen, Khalid al-Kofahi, et al.
Cancer Research|February 5, 2003
A novel subclass of thalidomide analogue with anti-solid tumor activity in which caspase-dependent apoptosis is associated with altered expression of bcl-2 family proteinsJ Blake Marriott, Ian A Clarke, Anna Czajka, et al.
Bioorganic & Medicinal Chemistry|September 30, 2011
1,1-Diarylalkenes as anticancer agents: dual inhibitors of tubulin polymerization and phosphodiesterase 4Alexander L Ruchelman, Hon-Wah Man, Roger Chen, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2012
Isosteric analogs of lenalidomide and pomalidomide: synthesis and biological activityAlexander L Ruchelman, Hon-Wah Man, Weihong Zhang, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2003
Enhancement of cytokine production and AP-1 transcriptional activity in T cells by thalidomide-related immunomodulatory drugsPeter H Schafer, Anita K Gandhi, Michelle A Loveland, et al.
Microvascular Research|September 23, 2008
The anti-cancer drug lenalidomide inhibits angiogenesis and metastasis via multiple inhibitory effects on endothelial cell function in normoxic and hypoxic conditionsLing Lu, Faribourz Payvandi, Lei Wu, et al.
Pageof 2